Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Cardio3 raises EUR 31.7M

    Cardio3 BioSciences S.A. (Euronext:CARD) raised EUR 31.7 million ($36 million) through the sale of 713,380 shares at EUR 44.50 in a private placement with undisclosed institutional investors in the U.S. and Europe. UBS …

    Published on 2/27/2015
  • FINANCIAL NEWS: Chiasma closes $70M series E round

    Chiasma Inc. (Jerusalem, Israel) closed an oversubscribed $70 million series E round led by an undisclosed crossover fund. New investors Rock Springs Capital and Sofinnova Ventures participated, as did existing …

    Published on 2/27/2015
  • FINANCIAL NEWS: Viehbacher joins PureTech's board

    PureTech Ventures (Boston, Mass.) named former Sanofi (Euronext:SAN; NYSE:SNY) CEO Christopher Viehbacher to its board.PureTech CEO and Managing Partner Daphne Zohar said the board is involved in choosing thematic areas…

    Published on 2/27/2015
  • FINANCIAL NEWS: Illumina raises $40M for accelerator matching fund

    Illumina Inc. (NASDAQ:ILMN) raised $40 million from Viking Global Investors for its Accelerator Boost Capital fund, which will provide dollar-for-dollar matching funds for graduates of its Illumina Accelerator. The …

    Published on 2/26/2015
  • FINANCIAL NEWS: Lyric debuts with $20.4M series A

    Gastrointestinal newco Lyric Pharmaceuticals Inc. (South San Francisco, Calif.) raised $20.4 million in a series A round led by RiverVest Venture Partners; Sante Ventures; and Third Point Ventures. Aperture Venture …

    Published on 2/26/2015
  • FINANCIAL NEWS: Relypsa raises $150M in follow-on

    Metabolic and renal play Relypsa Inc. (NASDAQ:RLYP) raised $150.2 million through the sale of 3.9 million shares at $38.50. BofA Merrill Lynch; Cowen; Oppenheimer; Stifel; and Wedbush PacGrow were underwriters. Relypsa …

    Published on 2/26/2015
  • FINANCIAL NEWS: Funding roundup: Actavis, Xencor, Curis, Celldex, AMAG

    Actavis plc (NYSE:ACT), Xencor Inc. (NASDAQ:XNCR), Curis Inc. (NASDAQ:CRIS), Celldex Therapeutics Inc. (NASDAQ:CLDX) and AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) raised more than $8.9 billion in follow-on offerings on …

    Published on 2/25/2015
  • FINANCIAL NEWS: Uptake of Orexigen's Contrave outpaces rivals

    Orexigen Therapeutics Inc. (NASDAQ:OREX) said net U.S. sales of weight-loss drug Contrave naltrexone/bupropion were $6.5 million in 4Q14, its first quarter on the market.Partner Takeda Pharmaceutical Co. Ltd. (Tokyo:…

    Published on 2/25/2015
  • FINANCIAL NEWS: CNS play Prexton closes A round

    Prexton Therapeutics S.A. (Plan les Ouates, Switzerland) raised EUR 8.7 million ($9.9 million) in a series A round co-led by new investors Sunstone Capital and Ysios Capital. Existing investor MS Ventures also …

    Published on 2/24/2015
  • FINANCIAL NEWS: China's 3SBio aims to go public again

    3SBio Inc. (Shenyang, China) proposed an IPO on the Hong Kong Stock Exchange. Morgan Stanley; Goldman Sachs; and CITIC Securities International are underwriters.3SBio was traded on NASDAQ from 2007 until 2013, when …

    Published on 2/23/2015
  • FINANCIAL NEWS: amfAR launches $100M HIV initiative

    The Foundation for AIDS Research (amfAR) pledged $20 million to establish the amfAR Institute for HIV Cure Research, an academic center dedicated to curative research, and will award $80 million in complementary …

    Published on 2/20/2015
  • FINANCIAL NEWS: Bessemer unveils $1.6B fund

    Bessemer Venture Partners raised $1.6 billion for its BVP IX fund, which the firm will invest in several sectors including therapeutics and healthcare IT.BVP's portfolio includes endocrine and metabolic play Allena …

    Published on 2/19/2015
  • FINANCIAL NEWS: Lifecode raises $20.5M series A round

    Molecular diagnostics company Lifecode Inc. (Foster City, Calif.) raised $20.5 million in a series A funding led by Sequoia Capital; the Mayo Clinic; and Mayo Ventures. The company did not respond to a request for …

    Published on 2/19/2015
  • FINANCIAL NEWS: Merganser raises $28M in series A

    Hematology play Merganser Biotech Inc. (Newtown Square, Pa.) raised $28 million in a series A round led by new investor Novartis Venture Fund. New investors Frazier Healthcare; Sutter Hill Ventures; Osage University …

    Published on 2/19/2015
  • FINANCIAL NEWS: Neurocrine raises $250M in follow-on

    Neurocrine Biosciences Inc. (NASDAQ:NBIX) raised $250 million through the sale of 6.9 million shares at $36 in a follow-on underwritten by JPMorgan; Deutsche Bank; Jefferies; Barclays; Cowen; and Nomura.Last month, …

    Published on 2/19/2015
  • FINANCIAL NEWS: ACT Genomics raises $8M series A

    ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $8 million in a series A round led by President International Development, UMC Capital, Hotong Group, TaiAn Technologies and Hua Nan Venture Capital. The company …

    Published on 2/18/2015
  • FINANCIAL NEWS: Inotek raises $60M in IPO and notes offering

    Inotek Pharmaceuticals Corp. (NASDAQ:ITEK) was unchanged at $6 in its first day of trading on Wednesday after raising a combined $60 million in a downsized IPO and concurrent notes offering. Cowen; Piper Jaffray; …

    Published on 2/18/2015
  • FINANCIAL NEWS: Laguna raises $30M in B round

    Laguna Pharmaceuticals Inc. (La Jolla, Calif.) raised $30 million in a series B round led by new investors Versant Ventures and Frazier Healthcare. New investor BioMed Ventures and existing investor Sante Ventures also …

    Published on 2/17/2015
  • FINANCIAL NEWS: Quantum Genomics raises EUR 33.2M

    Quantum Genomics Corp. (Euronext:ALQGC) raised EUR 33.2 million ($37.9 million) through the sale of 5.3 million shares at EUR 6.30 in a public offering and private placement on the Alternext market of Euronext Paris …

    Published on 2/17/2015
  • FINANCIAL NEWS: Bellerophon falls after $60M IPO

    Bellerophon Therapeutics LLC (NASDAQ:BLPH) lost $3.03 (25%) to $8.97 in its first day of trading Friday after raising $60 million in an IPO on NASDAQ through the sale of 5 million shares at $12. The price valued …

    Published on 2/13/2015
  • FINANCIAL NEWS: Idera raises $75M in follow-on

    Idera Pharmaceuticals Inc. (NASDAQ:IDRA) raised $75 million through the sale of 20 million shares at $3.75 in a follow-on underwritten by Goldman Sachs; JPMorgan; and Piper Jaffray. Idera proposed the offering after …

    Published on 2/13/2015
  • FINANCIAL NEWS: Follow-on roundup: Achillion, Atara, Threshold

    Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), Atara Biotherapeutics Inc. (NASDAQ:ATRA) and Threshold Pharmaceuticals Inc. (NASDAQ:THLD) have raised a combined $218.5 million in follow-ons since market close on Wednesday…

    Published on 2/12/2015
  • FINANCIAL NEWS: Inovalon, Invitae price IPOs

    Bioinformatics company Inovalon Holdings Inc. (NASDAQ:INOV) and diagnostics play Invitae Corp. (NYSE:NVTA) each began trading on Thursday after pricing bumped-up IPOs.Inovalon shares were unchanged after the company …

    Published on 2/12/2015
  • FINANCIAL NEWS: Cidara raises $42M in series B

    Infectious disease company Cidara Therapeutics Inc. (San Diego, Calif.) raised $42 million in a series B round from undisclosed new and existing institutional investors. Cidara expects to start a Phase I trial in 2H15 …

    Published on 2/11/2015
  • FINANCIAL NEWS: Israel's SteadyMed proposes $55M IPO

    SteadyMed Ltd. (Rehovot, Israel) filed to raise up to $55 million in an IPO on NASDAQ underwritten by Wells Fargo; RBC; and JMP.The company plans to submit an NDA to FDA in 1Q16 for Trevyent, a formulation of the …

    Published on 2/11/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993